Literature DB >> 11406527

Severe atherosclerotic changes, including aortic occlusion, associated with hyperhomocysteinaemia and antiphospholipid antibodies.

P E Spronk1, E H Overbosch, N H Schut.   

Abstract

Three patients are described with severe systemic atherosclerosis, including aortic occlusion, in the presence of a spectrum of risk factors, including hypercholesterolaemia, hypertension, a positive family history of cardiovascular problems, and hyperhomocysteinaemia. In all three patients high levels of anticardiolipin antibodies were found. The possible pathogenic role of antiphospholipid antibodies in atherosclerosis in the context of hyperhomocysteinaemia in these patients is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406527      PMCID: PMC1753754          DOI: 10.1136/ard.60.7.699

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Dyslipidemia and its relationship with antiphospholipid antibodies in APS patients in North Kerala.

Authors:  Shajit Sadanand; Binoy J Paul; Emil J Thachil; Rejadheesh Meletath
Journal:  Eur J Rheumatol       Date:  2016-12-01

Review 2.  Systemic antiphospholipid syndrome and atherosclerosis.

Authors:  Luis J Jara; Gabriela Medina; Olga Vera-Lastra
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

3.  Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome.

Authors:  G Medina; D Casaos; L J Jara; O Vera-Lastra; M Fuentes; L Barile; M Salas
Journal:  Ann Rheum Dis       Date:  2003-07       Impact factor: 19.103

Review 4.  Atherosclerosis and antiphospholipid syndrome.

Authors:  Luis J Jara; Gabriela Medina; Olga Vera-Lastra; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.